STOCK TITAN
  1. Home
  2. Financials
  3. BIAF
  4. Revenue

bioAffinity Tech (BIAF) Revenue by Year

BIAF

bioAffinity Tech generated $6.2M in revenue in fiscal year 2025. This represents a decrease of 34.2% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $5.9M in revenue. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters bioAffinity Tech has filed alongside them.

FY2025 annual
Revenue $6.2M
YoY -34.2%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

BIAF Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-K
Revenue$5.9M$6.2M-34.2%$9.4M+18.5%$7.9M+164380.5%$5KN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

BIAF Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$1.5M+19.0%$1.4M-27.1%$1.6M-27.8%$1.4M-38.5%$1.3M-47.1%$1.9M-23.0%$2.2M-70.9%$2.4M+682.8%$2.4M+12047.4%$2.4M+161.3%$7.6M$300K-73.9%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More bioAffinity Tech financials

Frequently Asked Questions

What was bioAffinity Tech's revenue in fiscal year 2025?

bioAffinity Tech generated $6.2M in revenue in fiscal year 2025.

How fast is bioAffinity Tech's revenue growing?

bioAffinity Tech (BIAF) revenue fell by 34.2% year over year, from $9.4M to $6.2M in fiscal year 2025.

What is bioAffinity Tech's revenue over the last twelve months?

bioAffinity Tech (BIAF) reported $5.9M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

bioAffinity Tech (BIAF) reported $1.5M in revenue in Q2 2026. This represents an increase of 19.0% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what bioAffinity Tech (BIAF) reported on that line in every period on record.